Researchers Feel Impact of Shutdown As Grant Review Stops, Funding Runs Dry
In Brief: Gift To St. Jude: $1 Million McDonald’s Ticket; Leitch Elected President, ACS Texas Division
FDA carries Action On Two Cancer Drugs Over To 1996
NRC Reports Says NIH Security Of nuclear Materials a Problem
Letter to the Editor: Could Managed care Cause Drop In Accrual In Suramin Trial?
AACR, Kellogg’s Co. Sponsor Award
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
- NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
- Most Favored Nation drug pricing could put China on top
- Protecting the cure: Why the future of radiation oncology must be precision-guided









